Acquisition by Romano Sarah of 150000 shares of First Wave subject to Rule 16b-3

FWBIDelisted Stock  USD 0.61  0.03  4.69%   
Under 62% of FWBI Old's investor base is looking to short. The analysis of current outlook of investing in FWBI Old suggests that many traders are alarmed regarding FWBI Old's prospects. FWBI Old's investing sentiment shows overall attitude of investors towards FWBI Old.
  
Filed transaction by First Wave BioPharma Officer Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
First insider trading alert for acquisition of common stock by Romano Sarah, Officer: Chief Financial Officer, on 1st of May 2024. This event was filed by First Wave BioPharma with SEC on 2023-01-03. Statement of changes in beneficial ownership - SEC Form 4

FWBI Old Fundamental Analysis

We analyze FWBI Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FWBI Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FWBI Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

FWBI Old is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

FWBI Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with FWBI Old stock to make a market-neutral strategy. Peer analysis of FWBI Old could also be used in its relative valuation, which is a method of valuing FWBI Old by comparing valuation metrics with similar companies.

Peers

FWBI Old Related Equities

DRMADermata Therapeutics   10.38   
0%
34.0%
ZVSAZyVersa Therapeutics   7.86   
0%
25.0%
XFORX4 Pharmaceuticals   6.53   
0%
21.0%
IMMXImmix Biopharma   3.54   
0%
11.0%
PHIOPhio Pharmaceuticals   2.18   
0%
7.0%
ZURAZura Bio   3.91   
12.0%
0%
ICULMF Acquisition   4.85   
15.0%
0%
REVBRevelation Biosciences   8.57   
28.0%
0%
SONNSonnet Biotherapeutics   14.50   
47.0%
0%
CDIOCardio Diagnostics   21.92   
71.0%
0%
QNRXQuoin Pharmaceuticals   30.51   
100.0%
0%
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in FWBI Stock

If you are still planning to invest in FWBI Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FWBI Old's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine